Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Codexis to Present at 16th Annual BIO CEO & Investor Conference



Codexis to Present at 16th Annual BIO CEO & Investor Conference

REDWOOD CITY, Calif., Feb. 4, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc.
(Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and
complex chemistry industries, today announced that John Nicols, President and
CEO of Codexis, will present a company overview at the 16^th Annual BIO CEO &
Investor Conference on Tuesday, February 11, 2014 at 1:00 p.m. ET in New York
City.

A live webcast and replay will be available on the Investors section of the
company's website, http://ir.codexis.com/.

About Codexis, Inc.

Codexis, Inc. is a leading developer of biocatalysts for the pharmaceutical
and complex chemistry industries. Codexis' proven technology enables scale-up
and implementation of biocatalytic solutions to meet customer needs for rapid,
cost-effective and sustainable process development – from research to
manufacturing. For more information, see www.codexis.com.

CONTACT: Codexis, Inc.
         Investors
         Paul Cox, 212-362-1200
         ir@codexis.com
        
         Media
         Jemma Connor, +44 161 359 3255
         jemma.connor@notchcommunications.co.uk

Codexis logo
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement